Media and Investors Resources

Press Release, 3 October 2022

Adhoc Press Release

Kuros Biosciences Appoints Chris Fair as Chief Operating Officer

Press Release, 15 September 2022

Adhoc Press Release

Kuros Biosciences announces successful CHF 6.0 million private placement

Press Release, 23 August 2022

Kuros Biosciences’ MagnetOs Bone Graft Successfully Achieves Three Key Milestones

Kuros Interim Results, 2022

English version

Press Release, 9 August 2022

Adhoc Press Release

Kuros Biosciences reports results for the first six months of 2022

Minutes of the AGM, 8 June 2022

German version